, have also been explored and found to be sensitive not only to infections but also to major inflammatory states, such as systemic inflammatory response syndrome (SIRS). In a recent study, has CD64 expression was measured on neutrophils from 450 patient samples using a point-of-care microfluidic device. This approach was found to be useful for predicting patient prognosis but provided limited utility in sepsis diagnosis 8 . Similarly, many other markers fail to differentiate between sepsis and systemic inflammatory responses 9, 10 and have therefore had limited practical effects. Microbiological cultures help to diagnose sepsis, but require extended periods of time (2-3 days) to grow out the bacteria, and are not available to inform early diagnosis and treatment.
Neutrophil dysfunction is a hallmark of sepsis, contributing to weak immune responses to the causative infections, as well as additional off-target organ damage [11] [12] [13] . Neutrophils from patients with sepsis lose the ability to respond appropriately to chemotactic signals 14, 15 and have altered antimicrobial activity 16 . Pharmaceutical correction of neutrophil behaviour during sepsis has been shown to improve outcomes in animal models 17 , suggesting that neutrophil dysregulation contributes to the severity of sepsis. Our previous studies identified a sepsis-specific spontaneous motility signature displayed by isolated ex vivo neutrophils in straight microfluidic channels, which enabled the prediction of sepsis in patients with major burns with 80% sensitivity and 77% specificity 15 . Neutrophils are sensitive to a diverse range of circulating factors and integrate these signals to modulate their activation state and behaviour accordingly. Thus, their activation during sepsis is probably the cumulative effect of inflammation-and infection-related factors that are present in the circulation, including many of the putative sepsis biomarkers discussed above. By measuring neutrophil behaviour, we have previously revealed changes even after the neutrophils had been isolated from blood 15 . Therefore, we hypothesized that measuring neutrophil motility using whole-blood samples might amplify the behavioural changes that we have previously observed in isolated neutrophils.
Here, we engineered a microfluidic device for measuring the phenotype of neutrophils in the context of sepsis. We measured neutrophil spontaneous motility through mazes of channels and identified key features of this phenotype that are relevant to sepsis. We show that interactions between neutrophils and plasma are critical for the spontaneous motility phenotype. We find that, when performed in the context of whole blood, neutrophil testing enabled, in a case-control study on patients in intensive care units, a precision of sepsis diagnosis that was better than 98%. Overall, our
Diagnosis of sepsis from a drop of blood by measurement of spontaneous neutrophil motility in a microfluidic assay results
Design of the microfluidic device. We designed a microfluidic device with channels and mazes ( Fig. 1 ) to measure complex neutrophil motility patterns using blood samples taken from critically ill patients. After loading, the blood sample is static and neutrophils motility is autonomous, in the absence of chemoattractant gradients. Measurements of neutrophil spontaneous motility patterns revealed significant differences between patients with and without sepsis. Several design elements of the microfluidic device enable measurements to be taken using diluted whole blood and with high precision. A single loading chamber contains a small (approximately 1 µ l) sample volume (Fig. 1a) and a red blood cell (RBC) filter 18 at the periphery of the chamber to facilitate the confinement of the sample to the centre of the device. The RBC filter uses 4.5 × 4 µ m cross-section channels and mechanically counteracts the passive movement of RBCs in the lateral direction during blood sedimentation, preventing entrance of RBCs into the assay field. At the same time, the channels of the RBC filter are large enough to allow the passage of motile neutrophils to the assay field (Fig. 1a,b) . The RBC filter also prevents the entrance of other leukocytes that are larger and less deformable compared to human neutrophils. We validated the efficacy of the RBC filter by counting the number of RBCs advancing (1.2 ± 1.9 RBC advancing per channel, n = 1520 channels scored, n = 10 devices). We validated the selectivity for neutrophils by monitoring the shape of the nucleus for leukocytes advancing through the filter. We observed the neutrophil-characteristic polylobated nucleus in more than 96% of cells entering the assay field (n = 131 out of 133 cells scored for non-sepsis samples, 336 out of 347 cells scored for sepsis samples. n = 6 devices monitored in detail per condition). Platelets were observed to enter migration channels but did not appear to obstruct neutrophil migration. In combination with the migration channels, the RBC filter enabled us to measure neutrophil motility velocity and directional persistence with high precision and to avoid the mechanical interference of RBCs to moving neutrophils. The design of migration channels as geometrical mazes enabled the measurement of directional choices and allowed neutrophils to reverse the direction of migration relative to the location of the blood droplet (Figs. 1a and 2a) .
Identification of sepsis-specific neutrophil motility patterns. We hypothesized that specific features of spontaneous neutrophil motility would differentiate patients with sepsis from patients without sepsis. To test this hypothesis, we characterized neutrophil motility patterns inside the channels (Supplementary Video 1) using a comprehensive set of 13 motility parameters (Supplementary Table 1 ). The blood samples for neutrophil testing were obtained from a derivation cohort of patients in the intensive care unit at the Massachusetts General Hospital, which included patients with and without sepsis (half of the patients without sepsis exhibited SIRS; Supplementary Tables 2 and 3) .
To identify the motility characteristics that segregated the patients based on their condition, in an unbiased manner, we applied a machine-learning approach ( Supplementary Fig. 1 , see Methods). Initially, unsupervised self-organizing feature mapping approaches were attempted, but could not be applied efficiently because of the small number of samples. A supervised machinelearning approach (support vector machines) was used instead. We trained the machine using samples from patients with and without sepsis ( Supplementary Fig. 1a,b) . We used n = 72 samples obtained from 23 patients at multiple time points during their hospital stay. For machine training, all samples from one patient were in the same group. We assumed that these samples were independent. 
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From an initial set of 13 variables, this machine-learning approach identified a smaller set of 5 parameters that conferred maximum prediction accuracy (Fig. 2 Supplementary Fig. 1 ). These parameters included the neutrophil count (N), the number of oscillations (O) the neutrophils exhibited within the migration channels, the number of cells pausing (P) during spontaneous motility, reverse migration (R) of cells out of the device, and the average distance (D) migrated by the cells. Maximum distance travelled inside the channels was also found to confer accuracy. However, it was excluded from the score, because it was already represented by the average distance parameter. The maximum distance was also more susceptible to skewing by outliers. Although some individual parameters, such as the number of oscillations, already conferred excellent prediction accuracy in the derivation cohort ( Supplementary Fig. 1c) , we reasoned that a score combining multiple parameters might provide a more widely applicable diagnostic. The value of each parameter was further verified using a 'minus-one' approach, in which the contribution of each parameter was tested by removing it from the combinatory score. The final formulation of the sepsis score was defined based on a nonlinear formula that incorporated the five-selected neutrophil spontaneous motility parameters. This equation represents an evolution of our previous 'neutrophil activation score' 15 and multiplies the number of spontaneously migrating neutrophils by the sum of sepsis-associated behaviours (sepsis score = N(O + P + R + D) / 10 3 ). We tested the value of the scoring system by generating receiver operator characteristic curves and calculating the area under the receiver operator characteristic curve (AUC). We determined that a threshold sepsis score of 30 is optimal for discriminating between samples from patients with and without sepsis. Overall, the scoring system generated an AUC of 0.98 for comparison of patients without and with sepsis in this cohort, with 96.8% sensitivity and 97.6% specificity.
Assay robustness. The assay requires minimal handling. A droplet of diluted blood is pipetted directly into the central chamber of the device. Spontaneous neutrophil motility occurs in the absence of neutrophil chemoattractants, further reducing the complexity of assay preparation. The assay requires 4 h of time-lapse microscopy and 2.5 h of image processing and analysis to generate a sepsis score. Integration of real-time tracking and analysis into the imaging protocol using a dedicated imaging system might foreseeably reduce this time. Assessment of chip-to-chip reproducibility showed no significant variation between measurements of the same blood sample on distinct chips (average s.d. was 4.7%; Fig. 3a) . Testing the blood is optimal within the first 3 h after blood collection. It seems that neutrophil activity decreases as the blood ages (Fig. 3b) , with a global 30-47% drop in all parameters observed from 1.5 to 3 h after drawing of the blood sample. These results suggest that reducing the time between the blood collection and the assay will improve diagnostic performance.
Comparison of spontaneous motility patterns between neutrophils in diluted whole blood and neutrophils purified by immunomagnetic negative selection. We verified that the performance of the assay is due to the use of whole blood by comparing the motility parameters of neutrophils from the same blood samples, using either diluted whole blood or isolated neutrophils in the assay. The concentration of the isolated neutrophil sample was adjusted to match the density of neutrophils in the blood. This comparison showed that some parameters, such as neutrophil count and pausing, were consistently increased in patients with sepsis when measured either in blood or isolated neutrophil samples (Fig. 4a,c) . Interestingly, oscillation was better able to separate patients with sepsis from those without in the blood assay than in the isolated neutrophil assay (Fig. 4b) . The changes in parameter values between samples from patients with and without sepsis were of larger magnitude when analysed in the context of blood compared to isolated neutrophils for all parameters except the reverse migration. However, reverse migration and average distance migrated were increased for samples from patients with sepsis in the blood assay but decreased with sepsis in the isolated neutrophil assay (Fig. 4d,e) . Overall, analysis of neutrophil motility patterns in the whole-blood assay magnifies the behavioural differences and enables more accurate discrimination between blood samples from patients with and without sepsis. We compared sepsis scores from assays run in parallel on multiple devices. We observed no significant differences. n = 10 blood samples. b, Comparison of sepsis scores from assays repeated at various times after the drawing of blood, with blood stored at room temperature. Sepsis scores decreased as the blood ages. n = 17 blood samples.
Septic neutrophil spontaneous motility signatures are driven by cell-autonomous pathways and extracellular stimuli. We decoupled the contribution to the neutrophil-autonomous and extracellular, plasma factors to the sepsis score by exchanging plasma between blood samples from healthy donors and patients with sepsis. We found that neutrophils from septic blood continued to exhibit spontaneous motility in the presence of healthy plasma, confirming that cell-autonomous factors in septic neutrophils have the dominant contribution to the sepsis score. This observation also suggests that the spontaneous motility phenotype is maintained in the presence of healthy plasma (Fig. 5a ). Interestingly, neutrophils from healthy blood displayed spontaneous motility patterns following incubation in septic plasma. This suggests that extracellular factors present in the septic blood also contribute to the sepsis score ( Fig. 5b ). Spontaneous motility was not stimulated by the presence of non-autologous plasma or by the experimental procedure. In control experiments, exchanging plasma between healthy blood samples did not result in stimulation of spontaneous neutrophil motility. Attempts to recapitulate a sepsis-like neutrophil phenotype by spiking whole blood with various individual immune modulators that have previously been reported to be elevated in septic blood were unsuccessful at inducing spontaneous motility patterns (Supplementary Table 6 ). These observations suggest that neutrophils integrate multiple signals over time when exposed to the altered blood environment present during sepsis, which ultimately induces cell-intrinsic pathways that drive the spontaneous motility patterns that we observed.
Validation of the sepsis score in a second, independent patient cohort. The sepsis score performed well at separating sepsis from non-sepsis blood samples from patients in the primary derivation cohort. The sepsis score for blood samples collected at day 1 discriminated with perfect accuracy the patients with and without sepsis in the derivation cohort (Fig. 6a) . The sepsis score also exhibits a high degree of internal consistency. Continued monitoring of patients during their hospital stay demonstrated that their sepsis score appeared to remain elevated for up to three weeks (Fig. 6b) , . All five parameters were significantly increased in the whole-blood assay. In the isolated neutrophil assay, the reverse migration and average distance parameters were negatively correlated with sepsis. n = 70 samples, n = 23 patients. Data are mean ± s.e.m. Differences between parameters measured for samples from patients with and without sepsis are indicated for whole-blood (orange shaded areas) and isolated neutrophil (yellow shaded areas) assays.
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generally dropping before discharge. To further validate the sepsis score, we used a second, independent patient cohort, managed by a different clinical team than the derivation cohort. We further verified the diagnostic accuracy of the sepsis score in a double-blind, prospective case-control study design. We calculated that the validation cohort should include at least 19 patients (10 with sepsis and 9 without sepsis) to demonstrate the improved performance of the assay compared to the current sepsis diagnostic standard. The size of the validation cohort was calculated based on the 96.8% sensitivity and 97.6% specificity of the assay inferred from the performance in the derivation cohort, the known sensitivity and specificity of the current sepsis diagnostic standard using sepsis-3 criteria (64% sensitivity and 65% specificity) 19 , and a 0.05 probability of a type-I error and 90% power 20 . Thus, the validation cohort consisted of 19 patients in intensive care with complex co-morbidities, who were selected as either cases with sepsis or controls. Of these, 10 patients had sepsis and 9 did not have sepsis (6 out of 9 patients without sepsis exhibited SIRS; Supplementary Tables 4 and 5 and Supplementary Fig. 2 ).
Multiple blood samples were collected from each patient at 1-3 day intervals. The clinical and research teams did not know the results of the assay or the status of the patient, until un-blinding at the completion of the study.
Blinded scoring of neutrophil behaviour from the first blood samples (day 1) that were collected from each patient demonstrated that the sepsis score provided accurate segregation of non-septic and septic samples (Fig. 6c) . Moreover, all 23 out of 23 samples collected at 1-3 day intervals from patients without sepsis all had sepsis scores < 30, whereas 26 out of 27 septic samples scored > 30, suggesting that the sepsis score could provide a valuable tool for monitoring patients with and without sepsis over time (Fig. 6d) . In the validation cohort, using the neutrophil assay, sepsis was diagnosed with 96.3% sensitivity and 100% specificity. This result substantiates the applicability of the sepsis score to sepsis diagnosis for a broad spectrum of at-risk patients. The analysis of the assay performance in the two cohorts combined (n = 42 patients) shows that the sepsis score achieved an overall AUC of 0.99, with 97% sensitivity and 98% specificity. ) ; unpaired, two-tailed t-test. b, Patients were followed longitudinally and their sepsis score was monitored for up to four weeks. Most sepsis scores appeared to drop towards non-septic ranges prior to discharge. Arrowheads indicate scores that were adjusted from 0 to 0.01 for presentation using a logarithmic scale. n = 70 samples, n = 23 patients. Sepsis scores for patients with sepsis are shown in red; sepsis scores for patients without sepsis are shown in blue. c, The sepsis score measured in day-1 blood samples was significantly higher for initial samples in the independent, double-blind validation cohort (n = 19 patients). Box and whisker plots, Tukey's box plot (see Methods); unpaired, two-tailed t-test. d, Patients from the validation cohort were also followed longitudinally and their sepsis score was monitored over weeks. Again, most sepsis scores appeared to drop towards non-septic ranges before discharge, but no overlap was observed between non-sepsis and sepsis groups in this cohort. Arrowheads indicate scores that were adjusted from 0 to 0.01 for presentation using a logarithmic scale. n = 50 samples, n = 19 patients. Sepsis scores for patients with sepsis are shown in red; sepsis scores for patients without sepsis are shown in blue.
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Discussion
The assay that we describe measures the patterns of neutrophil spontaneous motility and enables accurate diagnosis of sepsis in patients. The assay performs the measurements directly from a droplet of diluted whole blood, preserving the physiological and biochemical environment of the neutrophils. The ability to use whole blood distinguishes this assay from previous ones, which could only probe the motility of patient neutrophils after isolation from blood 15 . Moreover, we show that retaining plasma in the assay is critical for differentiating neutrophil motility patterns between patients with and without sepsis. Removal of plasma factors during neutrophil isolation results in changes in neutrophil phenotype and compromises discrimination between sepsis and non-sepsis conditions.
The design of the assay takes advantage of the higher precision measurements inherent to neutrophil motility through narrow microfluidic channels 14, 15, 21 . Despite limiting the richness of observable behavioural traits, the confinement of motile neutrophils to channels and the restriction to simple directional decisions results in measurements that are less sensitive to the noise from the small, continuous directional changes that affect traditional cell migration assays 21 . From the set of 13 motility parameters that we defined from these measurements, we used a machine-learning approach to identify those that corresponded to retrospective sepsis diagnosis. Three more neutrophil spontaneous motility parameters (pausing, reverse migration and average distance) were found to be essential for the sepsis score, in addition to the oscillation phenotype and the number of neutrophils entering the channels, which were previously identified as markers of sepsis using a purifiedneutrophil assay 15 . Two of these parameters were enabled by the design of the microfluidic channels. The mazes at the end of channels allowed more neutrophils to reverse their direction of migration and travel back to the location of the blood droplet. The mazes also allowed the neutrophils to travel larger average distances in the absence of directional cues. Both parameters increased in sepsis versus non-sepsis samples when analysed in blood and decreased when analysed in isolated neutrophils. Moreover, the fraction of cells to slow down their migration significantly and stop (pausing) emerged as an important parameter for the sepsis score in this geometrical context. Neutrophils have long been thought to have a role in septic responses 22 . They are an essential cell type for combating infections, boasting a wide range of potent antimicrobial mechanisms. Their functional deficiencies during sepsis may explain the poor control of infections. In addition, deregulated neutrophil entrance into tissues can result in the off-target deployment of these defensive mechanisms, which can cause tissue damage to bystander organs 11 . Treatment with molecules that correct aspects of neutrophil dysfunction in sepsis 17 have been shown to have a positive impact on outcome in animal sepsis models. These studies suggest that neutrophils have a direct role in promoting the cytokine storm and subsequent organ failure that leads to mortality in sepsis. For patients that were followed longitudinally, 2 out of 11 sepsis patients exhibited sepsis scores in the healthy range by the time they were discharged and 9 out of 11 showed a decrease (by 76% on average) in sepsis score before discharge. This decrease suggests a return of neutrophils towards homeostasis and may correlate with successful treatment. The results also indicate that sepsis may exert an extended temporal impact on neutrophil phenotype. Further studies will be needed to clarify the importance of these correlations and may guide the development of new treatment regimens to correct neutrophil activity and eventually ameliorate sepsis.
The biology underpinning the activation of neutrophils during sepsis remains mostly unexplored. Our study indicates the presence of extracellular factors in septic plasma that drive self-perpetuating alterations of neutrophil functionality. Factors such as the activation of C-reactive protein 23 may affect neutrophils, while also contributing to other phenotypes, for example, rouleaux formation 24 . Platelet activation has also been widely reported in sepsis [25] [26] [27] and has been suggested as a candidate rapid-response element during disease 28 . A previous study has demonstrated that activated platelets could induce spontaneous neutrophil motility and oscillatory motility patterns 29 . Although no single factor has yet been identified that can accurately stratify sepsis from non-sepsis, in combination, these responses probably contribute to the specific neutrophil spontaneous motility signatures that we capture using the whole-blood assay presented here. Our preliminary efforts to identify such factors, by the spiking experiments, reveal a complex situation in which neutrophil incubation with individual pro-inflammatory cytokines fails to induce the spontaneous motility phenotype. Future identification of inflammatory cocktails and temporal sequences of stimulation that are able to recapitulate sepsis-like spontaneous motility patterns from healthy blood will provide a useful tool to screen for compounds suppressing this phenotype, which is likely to be essential for improving clinical outcomes. Additionally, pinpointing specific molecules driving the neutrophil responses that we observe may allow alternative diagnostic strategies, in which the combination of factors might be rapidly measured directly from the plasma.
The present approach to sepsis diagnosis relies on neutrophil motility changes measured in the presence of plasma. The assay is logistically simple because it circumvents the need for neutrophil isolation procedures. In a clinical setting, the assay will require only the training of an operator who will prepare and load the blood sample in the device. Automated imaging and analysis of cell trajectories will then generate a sepsis score readout. The formula for the sepsis score and threshold values will have to be further refined and validated in subsequent research studies. The striking performance of the assay in the case-control study brings a new focus on the fundamental role that neutrophils have during sepsis. In addition to the potential for better understanding sepsis pathology, the assay for neutrophil behaviour may also become an essential tool for sepsis diagnostis and monitoring. Future validation of the assay in larger and more diverse cohorts of patients at risk of sepsis will eventually lead to valuable new diagnostic tools for the physicians treating patients with sepsis.
Methods
Device design and fabrication. Devices were designed using AutoCAD. Chrome masks for photolithography were printed by FrontRange Imaging. Silicon wafers were fabricated using standard techniques. In brief, clean silicon wafers were spincoated with two layers of negative photoresist (SU-8, Microchem, Newton, MA); the first layer was 4 µ m thick and the second 45 µ m. The wafer was then patterned by sequential ultraviolet light exposure through two photolithography masks, and processed per the manufacturer's instructions. The patterned wafer was then used as a mould for polydimethylsiloxane (Fisher Scientific, Fair Lawn, NJ) soft lithography to produce the final polydimethylsiloxane devices. Central inlets were punched using a 1.2-mm punch (Harris Uni-core). The whole device was punched out using a 5-mm punch. Devices were then irreversibly bonded to glass-bottom well plates, as previously described 30 .
Patient diagnostic criteria and study design. This observational study complied with current human research ethical regulations and was approved by the Massachusetts General Hospital Institutional Review Board. Subjects were consenting adults > 18 years and < 80 years, in two patient cohorts. A derivation cohort of 23 patients included trauma and postoperative surgical patients admitted to the surgical intensive care unit for trauma or surgical management (injury severity scores greater than 15, critically ill or postoperative patients with indwelling lines). Data collected from the derivation cohort of patients was used to optimize the analysis and machine learning. Subsequently, a validation cohort of 19 patients admitted to cardiac, medical, and surgical intensive care units was enrolled and used for the double-blind validation of the assay. Patients were evaluated using the recent sepsis-3 guidelines published in 2016, which defined sepsis as endorgan dysfunction caused by the host response to infection 1, 2 . This dysfunction is quantified by the SOFA score, which considers the different organ systems and the degree of dysfunction in each one. Following these recent guidelines, septic shock was defined as hypotension requiring vasopressors to maintain a mean arterial pressure greater than 65 mm Hg, and a serum lactic acid above 2 mmol dl −1 despite adequate fluid resuscitation.
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In addition, patients in the first, derivation cohort were evaluated based on the older definition of SIRS. The SIRS criteria were previously used to define a global inflammatory response, which, in the setting of an infection, comprised the definition of sepsis. In the setting of the SIRS criteria, septic shock included lactic acidosis and hypotension despite adequate fluid resuscitation. The SIRS criteria included temperature dysregulation-hyperthermia (> 38 °C) or hypothermia (< 36 °C)-heart rate > 90 beats per min, respiratory rate > 20 breaths per min or PaCO 2 < 32 mm Hg, and white blood cells > 12,000 per mm 3 or < 4,000 per mm 3 or > 10% bands.
All blood samples were drawn with consent from patients with existing venous lines that were expected to remain in place for more than 48 h. The first sample was drawn within the first seven days of admission to intensive care. Thereafter, a blood sample was drawn every three days for up to four weeks or until the patient was discharged, relocated to another unit or developed sepsis. During periods of sepsis, samples were drawn daily. Removal of the indwelling line automatically excluded (removed) a patient from the study.
Sample preparation. Devices were primed with Iscove's modified Dubecco's medium (IMDM) containing 20% fetal bovine serum (FBS) and 1% fibronectin (from human plasma, Sigma-Aldrich) by pipetting 50 µ l in and around each device. A dome of liquid formed on top and the outer edge of the device in contact with the coverslip was also surrounded by liquid. The devices were placed under vacuum for 10 min, then removed and allowed to equilibrate for at least 15 min until all channels had filled. IMDM containing 20% FBS was then added to the well containing the device until the device was completely covered. Devices for isolated neutrophils were primed as previously described 14, 15 . Peripheral blood samples from patients were drawn in 10 ml heparin-coated vacuum tubes (Vacutainer, Becton Dickinson) from indwelling lines. Some blood samples were split for comparison between the two assays using diluted whole blood (1 ml) and isolated neutrophils (9 ml). Whole-blood samples were diluted 1:1 in IMDM with 20% FBS and stained with Hoechst 33342 at 32 µ M for 15 min prior to loading. Subsequently, 0.5 µ l of stained blood was pipetted into the centre of the device using a gel-loading tip, taking care to draw the tip out of the device while dispensing.
Neutrophils were isolated from whole blood by density separation and negative selection (Neutrophil Enrichment Kit, STEMCELL Technologies, Vancouver, Canada) according to previously described protocols 14, 15 . To examine the shape of the nucleus, nucleated cells in blood were stained with 32 µ M Hoechst 33342 for 10 min, washed and re-suspended in IMDM containing 20% FBS at 2.0 × 10 7 cells per ml prior to loading. Devices for isolated neutrophils were loaded by pipette using a gel-loading tip until cells were observed to exit the device outlet.
For plasma-swapping experiments, 1 ml of whole blood was centrifuged at 200g for 10 min to pellet cells. The platelet-rich plasma supernatants were then drawn from the tubes and transferred into fresh tubes. Platelets were then pelleted at 1,900g for 10 min and the plasma fraction was transferred into new tubes. Cell pellets were then re-suspended in the appropriate exchanged plasma, incubated at room temperature for 30 min and an aliquot was loaded into the device.
For spiking experiments, peripheral blood from healthy volunteers aged 18 years or older was collected in heparin-coated vacuum tubes and delivered at room temperature to the lab within 1-6 h after collection (Research Blood Components). Immune modulators were added to the medium at twice the target concentrations, before mixing 1:1 with whole blood. After mixing, spiked blood samples were incubated at 37 °C for 30 min before loading into the device.
Imaging. Cell motility was imaged at 100× total magnification using a fully automated fluorescent Nikon TiE inverted wide field microscope with a biochamber heated to 37 °C with 5% CO 2 . Each microfluidic device provided eight fields of view, each containing one migration maze. Each field was imaged every 2 min to enable accurate tracking of cell motility, for 4 h. Datasets compromised by microscope failure were excluded from the data analysis.
Data analysis. Files were converted to standard AVI format using Nikon Elements or ImageJ. Initial processing was performed to enable bright-field tracking and included removal of the background. Cell tracking was performed automatically from bright-field images for most of the time-lapse sequences. The size, velocity and directionality of moving neutrophils was quantified. These tracks were written to individual CSV files for each imaging field. The specific variables for each track included: track number, video frame, cell diameter, x position, y position, distance and velocity. Automated cell tracking was performed using ImageCV, TrackPy and SciKit-Learn packages in Python. Cell motility pattern identification and definitions are detailed in Supplementary Machine learning. We performed supervised learning on neutrophils and patient data from the derivation cohort to identify and validate the group of parameters characteristic to sepsis. Support vector machines were then used to differentiate septic from non-septic patients in the derivation cohort [31] [32] [33] [34] . In brief, the data was split 1:2:1 (training:test:held-out) by patient. The algorithm was trained on the training dataset. Then, variables were changed and significant variables were determined on the testing dataset. These variables included the number of cells, spontaneous motility distance, oscillations, reverse migration and pausing. With these variables, final graphs and results were produced with the held-out set. To further optimize the sepsis classification parameters, regularized linear discriminant analysis was applied via hold-out analysis with cross-validation and multiple resampling owing to the few samples and increasing number of parameters 35 . With these parameters, error estimation was applied to all possible subsets to find the parameters that resulted in the highest accuracy sepsis prediction 36 . t-distributed stochastic neighbor embedding graphs 37 were produced to visually confirm the split of data by groups (sepsis and non-sepsis). Finally, the test-train split was changed and the analysis was run 500-1,000 times and a histogram of the AUC values from the held-out data was graphed.
Statistical analysis. The number of subjects needed to test the hypothesis that the level of performance for the proposed sepsis score is significantly higher than current diagnostic standards was calculated using asymptotic variance equations from Pepe 20 . For the calculations, we chose α = 0.05 as the desired minimum type-1 error rate, β = 0.1 the desired minimum type-2 error rate (90% study power). The sensitivity (64%) and specificity (65%) for sepsis of 2016 sepsis-3 diagnostic criteria were used as a reference. The desirable sensitivity and specificity levels for the proposed sepsis score were estimated from the first part of the study as 96.8% and 97.6%, respectively.
For comparison of patient samples, values are presented as Tukey box plots. The bottom and top of the box represent the first and third quartiles, respectively, and the centre line represents the median. Bottom and top whiskers represent the lowest and highest datapoint within 1.5 times the interquartile range, respectively. Outliers are represented by single points. For statistical analysis, comparisons of parameters for sepsis and non-sepsis groups were analysed using unpaired, twotailed t-tests, whereas comparisons of matched samples (Fig. 4) were analysed by paired, two-tailed t-tests. Graphing and statistical tests were performed using Prism 7.0a software (GraphPad Software Inc. The number of subjects needed in the validation cohort was calculated by using asymptotic variance equations. For the calculations, we chose α = 0.05 as the desired minimum type 1 error rate, and β = 0.1 as the desired minimum type 2 error rate (90% study power). The sensitivity (64%) and specificity (65%) for sepsis of 2016 Sepsis-3 diagnostic criteria were employed as reference. The desirable sensitivity and specificity levels for the proposed Sepsis Score were estimated from the first part of the study as 96.8% and 97.6%, respectively. The hypothesis tested was that the level of performance for the proposed Sepsis Score is significantly higher than current diagnostic standards.
Data exclusions
Describe any data exclusions. Patients for which the neutrophil motility recording was shorter than 2 hours, due to equipment failure or other circumstances, were excluded from the study.
Replication
Describe whether the experimental findings were reliably reproduced.
The work was designed as two prospective studies, on two independent cohorts of critically ill patients. In the first cohort, we applied machine-learning approaches to develop a scoring system that segregated patients with sepsis from those without sepsis. In the second cohort, we validated the scoring system by using the microfluidic assay in a double-blinded, prospective case-control study.
Assessment of chip-to-chip reproducibility showed no significant variation between measurements of the same blood sample on distinct chips.
When multiple blood samples were collected from the same patient, their Sepsis Score appeared to remain consistent with the septic/non-septic status of that patient for up to 3 weeks.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Patients in the intensive care unit were clinically defined as having sepsis when they were found to have a source of infection confirmed by blood, urine, or sputum culture, and evidence of organ dysfunction. Patients not fulfilling the clinical criteria for sepsis were classified as non-septic.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
We designed a double-blinded, prospective case-control study to verify the diagnosis accuracy of the Sepsis Score, as determined in a separate study. The clinical and research teams did not know the results of the assay or the true status of the patient, until unblinding at the completion of the study.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
Files were converted to standard AVI format using Nikon Elements or ImageJ. Initial processing was performed to allow brightfield tracking, and included removing the background. Cell tracking was performed automatically from brightfield images for most of the time-lapse sequences. Cells were tracked by size, velocity and directionality. These tracks were written to individual CSV files for each imaging field. The specific variables for each track included: track number, video frame, cell diameter, x position, y position, distance and velocity. Automated cell tracking was performed using ImageCV, TrackPy, and SciKit-Learn packages in Python. The codes used for analysis are available at http://doi.org/10.6084/m9.figshare.5572687
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
The design of the microfluidic devices used in this study will be made available upon request.
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species).
No antibodies were used. No eukaryotic cell lines were used.
